15hiv and aids ppt 4329

Upload: anurita-saigal

Post on 05-Apr-2018

228 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/31/2019 15hiv and Aids Ppt 4329

    1/13

    Immunodeficiencies 1

    HIV and AIDSChapter 15

    Self-Test

    Questions:Intro-A1: all

    A2: 1 & 2

    B1: 1 3, 5

    B2: 1, 3, 4

    B3: all

    C: 1 - 5

    D: all

    E & F: 3

    G: all

  • 7/31/2019 15hiv and Aids Ppt 4329

    2/13

    Immunodeficiencies and Cancer 2

    What causes immunodeficiencies?

    1O vs 2O immunodeficiencies

    Examples of 1O

    Lymphatic

    SCID

    DiGeorges

    Bare lymphocyte (no MHC)

    Agammaglobulinemia

    Myeloid

    Agranulocytosis

    e.g., neutropenia

    Nude mouse

  • 7/31/2019 15hiv and Aids Ppt 4329

    3/13

    Immunodeficiencies and Cancer 3

    What are causes of 2O Immunodeficiencies?-- acquired later in life

    Malignancies

    Nutritional deficiencies

    Stress

    Age

    Drugs

    Infections

  • 7/31/2019 15hiv and Aids Ppt 4329

    4/13

    Immunodeficiencies and Cancer 4

    What is the structure of HIV?-- HIV is a retrovirus

    Structure of HIV

    EnvelopeGP120 receptor

    Inner protein layer

    Capsid

    RNA

    RT & integrase enzymes

    What cells does HIV infect?Host cell ligands

    CD4

    Chemokine receptors

    CCR5

    CXCR4

    Target cells

    M-tropic: 1O macrophages (CCR5)

    T-tropic: 1O TH cells (CXCR4)

  • 7/31/2019 15hiv and Aids Ppt 4329

    5/13

    Immunodeficiencies and Cancer 5

    What genes are present in

    the HIV genome?

    9 genes, coding for 16 proteins

    FunctionsStructural

    Enzymatic

    Regulatory

    Precursor proteins

    HIV protease

  • 7/31/2019 15hiv and Aids Ppt 4329

    6/13

    Immunodeficiencies and Cancer 6

    How does HIV infect cells

    and replicate?

    Infection

    Receptor binding & membrane fusion

    Capsid entry & dissociation

    Release of RNA & enzymes

    -- Reverse Transcription

    Provirus integration in host DNA

    -- integrase activity

    Replication

    Provirus activation

    Protein and RNA synthesis

    -- protease activity

    Virion self-assembly & buddingMcGraw-Hill

    HIV Life Cycle

    http://www.marietta.edu/~spilatrs/biol430/animations/McGraw-Hill%20hiv_replication.swfhttp://www.marietta.edu/~spilatrs/biol430/animations/McGraw-Hill%20hiv_replication.swfhttp://www.marietta.edu/~spilatrs/biol430/animations/McGraw-Hill%20hiv_replication.swf
  • 7/31/2019 15hiv and Aids Ppt 4329

    7/13

    Immunodeficiencies and Cancer 7

    How does HIV

    Affect the immune

    response?

    Has effects on. . .

    TH1O target

    B-cells

    Tc and CTLs

    T-cell syncytia

    Why do these responses decline?

  • 7/31/2019 15hiv and Aids Ppt 4329

    8/13

    Immunodeficiencies and Cancer 8

    How does the immunological

    response change during the

    course of an HIV infection?

    1. Acute phase

    2. Chronic phase

    3. AIDS

  • 7/31/2019 15hiv and Aids Ppt 4329

    9/13

    Immunodeficiencies and Cancer 9

    What are the clinical categories

    of an HIV infection?

    Clinical PresentationA: typically mild symptoms

    B : moderate symptoms

    C : severe disease

    Immunological Status1: >= 500 TH cells /l blood

    2: 200499 /l

    3: < 200/l

    AIDS diagnosis HIV+

    < 200 TH cells /l blood

    1 or more AIDS associated diseases

  • 7/31/2019 15hiv and Aids Ppt 4329

    10/13

    Immunodeficiencies and Cancer 10

    Clinical course of HIV infection

  • 7/31/2019 15hiv and Aids Ppt 4329

    11/13

    Immunodeficiencies and Cancer 11

    Control of viral infections

    Antibiotics dont work

    Synthetic drugs-- treat symptoms

    -- slow viral replication

    Anti-HIV therapy4 classes

    Reverse transcriptase inhibitors

    1a) nucleotide analogse.g., AZT, ddl, ddc, etc

    1b) non-analog inhibitors

    e.g., nevirapine, etc

    2) protease inhibitors

    3) Fuzeon

    -- newest drug

    -- fusion inhibitor

    Combinational drug therapy (HAART)

    McGraw-Hill

    HIV Treatments

    http://www.marietta.edu/~spilatrs/biol430/animations/McGaw-Hill%20treatment_of_hiv.swfhttp://www.marietta.edu/~spilatrs/biol430/animations/McGaw-Hill%20treatment_of_hiv.swfhttp://www.marietta.edu/~spilatrs/biol430/animations/McGaw-Hill%20treatment_of_hiv.swf
  • 7/31/2019 15hiv and Aids Ppt 4329

    12/13

    Immunodeficiencies and Cancer 12

    Why is controlling

    AIDS in the

    developing world so

    difficult?

    Genetic variabilityHIV-1 and HIV-2

    HIV-1 Clades

    Mode of transmissionC&E mainly heterosexual

    Weak health care and

    educational systems

    Cost of AIDS drugs

    Complexity of drug regimen

  • 7/31/2019 15hiv and Aids Ppt 4329

    13/13

    Immunodeficiencies and Cancer 13

    Will there be an AIDS

    vaccine anytime soon?

    Current strategiesDNA vaccines

    Vector based vaccines

    Recent success with

    combined vaccine

    ChallengesAntigenic variability

    Difficulty getting CTL

    and humoral response

    Difficulty generating mucosyl-immunity

    Use of a live-attenuated vaccine is risky

    Etc.